Thread

By  Dave Muoio 02:24 pm August 21, 2020
Exo, a Silicon Valley company known for its in-development handheld ultrasound device, announced $40 million in new funding yesterday. GlaxoSmithKline's Investor Action Potential Venture Capital fund was among the Series B+ round's unnamed investors. Exo said in its announcement that it will be using the funds to wrap up product development for that device, and to bring its data and workflow apps...
By  Laura Lovett 01:44 pm August 28, 2019
Yesterday private equity firms Water Street Health Partners and JLL Partners announced that they had acquired virtual clinical research company Thread for an undisclosed amount. The new owners say they plan on investing in Thread in order to further expand its customer base and offer the platform on a global scale.  Thread’s platform is aimed at improving clinical trial research data and making...